Terms: = Breast cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Prognosis
8 results:
1. Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints.
Liu X; Xu F; Zhao K; Liu Y; Ye G; Zhang X; Qu Y
Front Immunol; 2024; 15():1344023. PubMed ID: 38312844
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract] [Full Text] [Related]
3. Cell-In-Cell Structures in Early breast cancer Are Prognostically Valuable.
Bauer MF; Hildebrand LS; Rosahl MC; Erber R; Schnellhardt S; Büttner-Herold M; Putz F; Ott OJ; Hack CC; Fietkau R; Distel L
Cells; 2022 Dec; 12(1):. PubMed ID: 36611874
[TBL] [Abstract] [Full Text] [Related]
4.
Kasten BB; Oliver PG; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561763
[TBL] [Abstract] [Full Text] [Related]
5. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
Zhao XL; Lin Y; Jiang J; Tang Z; Yang S; Lu L; Liang Y; Liu X; Tan J; Hu XG; Niu Q; Fu WJ; Yan ZX; Guo DY; Ping YF; Wang JM; Zhang X; Kung HF; Bian XW; Yao XH
J Pathol; 2017 Nov; 243(3):376-389. PubMed ID: 28802057
[TBL] [Abstract] [Full Text] [Related]
6. Recurrent cic Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract] [Full Text] [Related]
7. Inflammatory breast carcinoma: pathological or clinical entity?
Amparo RS; Angel CD; Ana LH; Antonio LC; Vicente MS; Carlos FM; Vicente GP
Breast Cancer Res Treat; 2000 Dec; 64(3):269-73. PubMed ID: 11200777
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
Aziz M; Akhtar S; Malik A
Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
[TBL] [Abstract] [Full Text] [Related]
